BioSpace News Archive

Deals

Agilent Expands Cell Analysis Portfolio with Acquisition of Luxcel Biosciences

This acquisition expands Agilent’s cell analysis portfolio with the addition of easy-to-use assay kits that are compatible with industry standard plate-readers.

January 9, 2018
·
6 min read
Pharm Country

Biohaven Announces Positive Results From Bioequivalence Study With Sublingual BHV-0223 Zydis Orally Dissolving Tablet

Biohaven announced positive results today from its bioequivalence study with BHV-0223, an innovative sublingual formulation of riluzole.

January 9, 2018
·
5 min read
FDA

Xcision Wins FDA 510(k) OK for Breast Cancer GammaPod Stereotactic Radiotherapy System

With GammaPod, radiation oncologists will be at the forefront of a new era in cancer care by providing stereotactic radiotherapy treatments for the breast.

January 9, 2018
·
4 min read
Genetown

Evelo Biosciences Announces Issuance of U.S. Patent Supporting Monoclonal Microbial Oncology Trials

Evelo announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,855,302 covering Bifidobacteria for the treatment of cancer in combination with checkpoint inhibitors.

January 9, 2018
·
4 min read
TTP Ventus Micropump Technology Enables Wearable Treatment for Sleep Apnea

Having recently received a Health Canada Medical Device License, aerSleep is now approved for marketing to patients in Canada. CE mark approval is expected Q4 2018.

January 9, 2018
·
2 min read
Business

Ascensia Diabetes Care Expands Strategic Alliance with Insulet Corporation by Signing Commercial Agreement

This follows the worldwide non-exclusive development agreement that Ascensia announced in June 2017 to connect its CONTOUR NEXT ONE BGMS with Insulet’s next-generation Omnipod System.

January 9, 2018
·
2 min read
Business

SCORR Marketing and Applied Clinical Trials Release Report on Clinical Research Industry Salary and Employee Satisfaction

The report, produced in partnership with Applied Clinical Trials, is based on a survey of its subscribers working at pharmaceutical and biotech companies, contract research organizations (CROs), research sites and academic institutions.

January 9, 2018
·
2 min read
Business

Orthofix Announces Preliminary 2017 Fourth Quarter and Full Year Net Sales Results

Orthofix today announced preliminary unaudited fourth quarter 2017 net sales of approximately $117 million.

January 9, 2018
·
11 min read
Biotech Bay

Exelixis to Co-Host Financial Community Briefing to Discuss Data Presented at the 2018 American Society of Clinical Oncology Gastrointestinal Cancers Symposium

The webcast event will be held following the closing of the ASCO-GI day’s sessions on Friday, January 19, 2018, beginning at 9:30 p.m. EST / 6:30 p.m. PST.

January 9, 2018
·
3 min read
Policy

Pulmonx Submits Premarket Approval (PMA) Application to U.S. FDA for Zephyr Endobronchial Valve as Treatment for Emphysema

The filing was based on the successful execution of Pulmonx’s pivotal IDE trial, the LIBERATE Study, a landmark randomized controlled trial that enrolled 190 patients with severe emphysema at 24 centers in the U.S. and Europe.

January 9, 2018
·
4 min read